it is now known that no two tumors are the same, even if they are in the same organ, and oncological research, as it studies the fine print of tumors revealed by molecular biology, is moving towards increasingly more personalized drugs, which are even tailored to each patient.
Fortunately, we have passed the stage of paternalistic medicine, and now we take into account patients' preferences, and they also decide what is best for them.
[
add
]
[
|
|
...
]